Video Shorts

Why gene therapies are harder to plan for in Medicaid

Real-world evidence, AI and the patient voice lead AMCP’s 2027 agenda

AMCP aims to close the real-world evidence gap between industry and payers

AMCP puts patient voice on its 2027 priority list

Can better sleep before surgery help reduce postoperative pain?

Earlier psychosis intervention may lower costs and improve schizophrenia care

Why measuring first episode psychosis is more complicated than it seems

My Two Cents: Christine Johnston on changing the PBM RFP test

Alison Pritchard, Ph.D., says the future of ADHD treatment depends on personalized treatments

Why separate approval committees for each CAR-T patient slow access to care

What it takes to scale outpatient CAR-T delivery

Real-time glucose data helps patients with type 2 diabetes lower A1C

Why eye care should be an integral part of the burn recovery process | AAO 2026

At home VR glaucoma testing could be the future of prevention | AAO 2026

Overlooked ocular aspects of healing from a severe burn | AAO 2026

Senior glaucoma patients interested in VR testing | AAO 2026

Chad Hatfield, PharmD, MHA, BCPS, on preparing for a 340B rebate model

The unexpected workplace benefits of covered GLP-1s

Alison Pritchard, Ph.D., on matching ADHD sleep care to family goals

Employers can't avoid every pharmacy benefit lawsuit, but they can limit the risk

Why employers must audit PBM contracts

How employers can navigate GLP-1 coverage costs

Real transparency means data plus an educational partner when it comes to drug costs

Transcranial magnetic stimulation is not electroconvulsive therapy

High deductibles make ACA enrollees question insurance value

Anti-sanctuary policies linked to rising HIV rates in Hispanic communities

The vicious cycle of sleep and ADHD

Why non-network health plans leave patients unprotected

Patient choice and policy advocacy go hand in hand in HIV prevention

Hyperactive-impulsive behaviors top indicators for ADHD preschoolers